107 related articles for article (PubMed ID: 11268462)
1. Altered expression of hMSH2 in sporadic colorectal cancer, surrounding mucosa and at distant colonic mucosa.
Giarnieri E; Consorti F; Lorenzotti A; Luzzatto L; Soda G; Bosco D; Vecchione A; Midiri G
Anticancer Res; 2000; 20(5C):3829-31. PubMed ID: 11268462
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
[TBL] [Abstract][Full Text] [Related]
3. [Genetics-based prognosis evaluation of patients surgically treated for sporadic colorectal cancer].
Midiri G; Consorti F; Giarnieri E; Soda G; Bosco D; Lorenzotti A; Luzzatto L; Conte S; Lo Russo M; Vecchione A; Beltrami V
G Chir; 2001 May; 22(5):165-8. PubMed ID: 11443839
[TBL] [Abstract][Full Text] [Related]
4. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
[TBL] [Abstract][Full Text] [Related]
5. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
7. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.
Leach FS; Polyak K; Burrell M; Johnson KA; Hill D; Dunlop MG; Wyllie AH; Peltomaki P; de la Chapelle A; Hamilton SR; Kinzler KW; Vogelstein B
Cancer Res; 1996 Jan; 56(2):235-40. PubMed ID: 8542572
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
9. Loss of hMSH2 expression in primary breast cancer with p53 alterations.
Spagnoletti I; Pizzi C; Galietta A; Di Maio M; Mastranzo P; Daniele S; Limite G; Pettinato G; Contegiacomo A
Oncol Rep; 2004 Apr; 11(4):845-51. PubMed ID: 15010883
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
11. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
12. [Expression of mismatch repair gene hMSH2 in human malignant ovarian tumors and its clinical significance].
Ma L; Zhang J; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):291-3. PubMed ID: 11775911
[TBL] [Abstract][Full Text] [Related]
13. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
[TBL] [Abstract][Full Text] [Related]
14. hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.
Ercoli A; Ferrandina G; Raspaglio G; Marone M; Maggiano N; Del Mastro P; Benedetti Panici P; Mancuso S; Scambia G
Br J Cancer; 1999 Jul; 80(10):1665-71. PubMed ID: 10408416
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
[TBL] [Abstract][Full Text] [Related]
16. Expression of the mismatch repair gene hMSH2 in sporadic colorectal cancer.
Maeda K; Nishiguchi Y; Onoda N; Otani H; Nakata B; Yamada S; Okuno M; Sowa M; Chung KH
Int J Oncol; 1998 Dec; 13(6):1147-51. PubMed ID: 9824623
[TBL] [Abstract][Full Text] [Related]
17. Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer.
Palicio M; Blanco I; Tórtola S; González I; Marcuello E; Brunet J; Lluis F; González-Aguilera JJ; Peinado MA; Capella G
Br J Cancer; 2000 Feb; 82(3):535-7. PubMed ID: 10682661
[TBL] [Abstract][Full Text] [Related]
18. No difference in stem cell somatic mutation between the background mucosa of right- and left-sided sporadic colorectal carcinomas.
Campbell F; Appleton MA; Shields CJ; Williams GT
J Pathol; 1998 Sep; 186(1):31-5. PubMed ID: 9875137
[TBL] [Abstract][Full Text] [Related]
19. The T/G mutation in exon 8 of hMSH2 gene in the sporadic colon cancer patients.
Langner E; Przybyłowska K; Przemysław G; Kunierz J; Smolarz B; Romanowicz-Makowska H; Migileski J; Kulig A; Dziki A
Acta Chir Iugosl; 2006; 53(2):57-60. PubMed ID: 17139886
[TBL] [Abstract][Full Text] [Related]
20. A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis.
Noffsinger AE; Belli JM; Fogt F; Fischer J; Goldman H; Fenoglio-Preiser CM
Hum Pathol; 1999 Jan; 30(1):8-12. PubMed ID: 9923920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
